end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AdditionalPaidInCapital,AllocatedShareBasedCompensationExpense,AmortizationOfDebtDiscountPremium,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,Cash,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,ClassOfWarrantOrRightOutstanding,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConvertibleNotesPayable,CostsAndExpenses,DeferredOfferingCosts,DeferredTaxAssetsGross,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOtherTaxCarryforwards,DeferredTaxAssetsValuationAllowance,DueFromRelatedPartiesCurrent,DueToRelatedPartiesCurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationOtherAdjustments,FederalIncomeTaxExpenseBenefitContinuingOperations,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,InterestExpenseRelatedParty,InterestIncomeExpenseNet,InterestReceivable,IssuanceOfStockAndWarrantsForServicesOrClaims,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebtAverageAmountOutstanding,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingIncomeLoss,OtherPrepaidExpenseCurrent,OtherReceivables,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockValue,PrepaidExpenseAndOtherAssets,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromCollectionOfNotesReceivable,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromNotesPayable,ProceedsFromShortTermDebt,ProceedsFromStockOptionsExercised,RepaymentsOfNotesPayable,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharesIssued,SharesOutstanding,StockholdersEquity,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2021-04-30,2021-07-29,10-K,"ALZAMEND NEURO, INC.",ALZN,CIK0001677077,USD,503593.0,33721859.0,2374046.0,124046.0,40084917.0,2912590.0,2912590.0,1900000.0,1929270.0,1838985.0,,0.0001,300000000.0,67429525.0,90102623.0,6743.0,335303.0,4951888.0,352502.0,4354645.0,3360381.0,994264.0,4354645.0,,60749.0,-0.07,0.0,0.21,-0.159,-0.051,5046567.0,62418.0,3641172.0,-5046567.0,-413242.0,-260791.0,142421.0,16382.0,1706.0,,,2912590.0,899645.0,,4450097.0,100915.0,-2712027.0,-5046567.0,-94679.0,-4951888.0,850.0,16210.0,0.0001,10000000.0,75.0,983320.0,983320.0,,100915.0,,2100000.0,62110.0,1850000.0,,1918.0,1310716.0,-16832437.0,2032359.0,,10450000.0,13460519.0,0.6729,,125000.0,35159500.0,19550000.0,0.7195,21178300.0,18500.0,0.9806,,,1.5,18423196.0,,67429525.0,2012945.0,,,,,72650073.0,
2021-07-31,2021-09-13,10-Q,"ALZAMEND NEURO, INC.",ALZN,CIK0001677077,USD,1072548.0,49371166.0,739622.0,4795.0,27012834.0,16817651.0,16817651.0,15600000.0,15618162.0,13688892.0,8830785.0,0.0001,,,86887858.0,8689.0,340098.0,2306239.0,,,,,,,60749.0,-0.03,,,,,,,1389831.0,,568955.0,216169.0,13628.0,,,,,16817651.0,1473395.0,14883295.0,14911556.0,,-1222664.0,-2319867.0,-13628.0,-2306239.0,786612.0,16210.0,0.0001,10000000.0,,1199489.0,1199489.0,,,1460000.0,2000000.0,,,100.0,,916408.0,,739622.0,,9250000.0,,,300000.0,1500000.0,72647100.0,20500000.0,0.8812,,,,0.0004,1.5,2.9167,,,,15344256.0,,,,100.0,84588492.0,
2021-10-31,2021-12-13,10-Q,"ALZAMEND NEURO, INC.",ALZN,CIK0001677077,USD,1128410.0,50652054.0,,,,14500896.0,14500896.0,13600000.0,13572692.0,,8830785.0,0.0001,300000000.0,88850358.0,,8885.0,344893.0,3583934.0,,,,,,,2182.0,-0.04,,,,,,,1833884.0,,,,15995.0,,,,,14500896.0,1475485.0,,,,,-3599929.0,-15995.0,-3583934.0,850.0,16210.0,0.0001,10000000.0,,928204.0,928204.0,584477.0,,,,,,,,1750050.0,-22752233.0,,,9000000.0,,,,,23458300.0,19000000.0,0.9826,,,,,,,,67429525.0,,13025411.0,,,,700.0,93458556.0,
2022-01-31,2022-03-15,10-Q,"ALZAMEND NEURO, INC.",ALZN,CIK0001677077,USD,464895.0,52161522.0,1130795.0,,,12429116.0,12429116.0,11800000.0,11790289.0,,8830785.0,0.0001,300000000.0,90102623.0,,9010.0,,2556566.0,,,,,,,2082.0,-0.03,,,,,,,1682913.0,,,,16299.0,,,,,12429116.0,466977.0,,,,,-2572865.0,-16299.0,-2556566.0,11981.0,,0.0001,10000000.0,,638827.0,638827.0,370179.0,,,,,,,,873653.0,-25325098.0,,,9000000.0,13460519.0,0.7891,,,13118800.0,18000000.0,0.9826,1.0,16000000.0,1.0418,,,,9806358.0,67429525.0,,11962139.0,,,,400.0,,378398.0
